Antimicrobial Resistance Practice Questions

Q: A 65-year-old male underwent emergency laparotomy for perforated duodenal ulcer 5 days ago. He now develops fever (38.5°C), productive cough, and increased oxygen requirement. Chest X-ray shows a new right lower lobe infiltrate. Gram stain of endotracheal aspirate shows Gram-negative bacilli, and culture grows lactose-fermenting colonies that are oxidase-negative and produce a metallic sheen on EMB agar. The isolate is resistant to ampicillin and third-generation cephalosporins but sensitive to cefoxitin (a cephamycin). Resistance is inhibited by clavulanic acid in disk synergy testing. The isolate is also resistant to fluoroquinolones, but sensitive to carbapenems and colistin. What is the most likely mechanism of antibiotic resistance in this organism?

Extended-spectrum beta-lactamase (ESBL) production. ***Extended-spectrum beta-lactamase (ESBL) production*** - **E. coli** with resistance to **third-generation cephalosporins** but sensitivity to **cefoxitin** (cephamycin) is classic for **ESBL production**. - The positive **disk synergy testing** with **clavulanic acid inhibition** is pathognomonic for **ESBL enzymes**, which are inhibited by beta-lactamase inhibitors. *AmpC beta-lactamase hyperproduction* - **AmpC producers** are typically resistant to **cefoxitin** (cephamycins), unlike this isolate which is sensitive. - **AmpC enzymes** are **NOT inhibited by clavulanic acid**, contradicting the positive disk synergy test described. *Carbapenemase production* - This mechanism is ruled out as the isolate is explicitly **sensitive to carbapenems** (imipenem, meropenem). - **Carbapenemase-producing Enterobacteriaceae** would show high-level resistance to all **carbapenem antibiotics**. *Porin channel mutation with efflux pump overexpression* - These mechanisms rarely provide the **high-level, specific resistance** to third-generation cephalosporins seen here. - **Efflux pumps** typically cause **low-level, multidrug resistance** patterns rather than the specific beta-lactam resistance profile described.

Q: A cluster of pneumonia cases is reported from a city with high mortality rate. Sputum cultures show gram-negative coccobacilli resistant to multiple antibiotics including carbapenems. Gene sequencing reveals blaNDM-1. What is the most critical factor contributing to this emerging resistance?

Horizontal gene transfer through plasmids. ***Horizontal gene transfer through plasmids*** - The **blaNDM-1** gene (New Delhi Metallo-beta-lactamase) is typically carried on highly mobile **plasmids**, enabling rapid dissemination between different bacterial species. - This mechanism is the most critical driver for the **global spread** of carbapenem resistance, often carrying multiple other resistance genes simultaneously. *Point mutations in chromosomal DNA* - While mutations can cause resistance to some drugs (like fluoroquinolones), they are **vertical** and generally slower than the rapid cluster outbreaks caused by **horizontal transfer**. - The **blaNDM-1** gene is an acquired genetic sequence, not a result of a singular point mutation in common **gram-negative coccobacilli** chromosomes. *Decreased porin expression* - Porin loss can lead to **carbapenem resistance** by preventing drug entry into the periplasm, often seen in *Pseudomonas* or *Klebsiella*. - However, this is a **structural modification** that usually works in synergy with enzymes rather than being the primary factor defined by the **blaNDM-1** gene. *Efflux pump mechanisms only* - Efflux pumps actively transport various antibiotics out of the cell, contributing to **multidrug resistance (MDR)**. - While they contribute to the phenotype, the question specifically identifies **blaNDM-1**, which is a **metallo-beta-lactamase enzyme** that enzymaticallly degrades the antibiotic, not a pump mechanism.

Q: Which of the following drugs should not be used to treat Klebsiella infection?

Ampicillin. ### Explanation The correct answer is **Ampicillin**. **1. Why Ampicillin is the correct answer:** *Klebsiella pneumoniae* possesses a **constitutive (intrinsic) resistance** to Ampicillin and Amoxicillin. This is due to the presence of chromosomally mediated **SHV-1 beta-lactamase** enzymes that hydrolyze these penicillins. Therefore, Ampicillin is clinically ineffective against *Klebsiella* species regardless of the strain's sensitivity profile in the lab. **2. Analysis of Incorrect Options:** * **B. Amikacin:** This is an Aminoglycoside often used as part of a combination therapy for serious Gram-negative infections, including *Klebsiella*. * **C. Imipenem:** A Carbapenem that remains one of the most potent drugs against *Klebsiella*, particularly for Extended-Spectrum Beta-Lactamase (ESBL) producing strains. However, resistance is rising due to Carbapenemases (KPC). * **D. Tigecycline:** A Glycylcycline used as a "reserve drug" for Multi-Drug Resistant (MDR) *Klebsiella*, including Carbapenem-Resistant Enterobacteriaceae (CRE). **3. High-Yield Clinical Pearls for NEET-PG:** * **Intrinsic Resistance:** Always remember that *Klebsiella* is naturally resistant to Ampicillin. Similarly, *Proteus mirabilis* is intrinsically resistant to Nitrofurantoin, and *Pseudomonas* is resistant to many common antibiotics like Tigecycline. * **ESBL Production:** *Klebsiella* is a frequent producer of ESBLs, which confer resistance to 3rd generation Cephalosporins (Ceftriaxone, Ceftazidime). The drug of choice for ESBL-producing *Klebsiella* is a **Carbapenem**. * **Morphology:** On MacConkey agar, *Klebsiella* produces large, mucoid, pink colonies (Lactose Fermenter) due to its prominent polysaccharide capsule.

Q: Enzyme inactivation is the main mode of resistance to which class of antibiotics?

Aminoglycosides. **Explanation** The primary mechanism of resistance to **Aminoglycosides** (e.g., Gentamicin, Amikacin) is the production of **Aminoglycoside Modifying Enzymes (AMEs)**. These bacterial enzymes (phosphorylases, adenyltransferases, and acetyltransferases) modify the antibiotic molecule, preventing it from binding to the 30S ribosomal subunit. While other mechanisms like efflux pumps and ribosomal mutations exist, enzyme inactivation is clinically the most significant and common mode of resistance. **Analysis of Incorrect Options:** * **Quinolones (e.g., Ciprofloxacin):** Resistance is primarily due to **target site mutations** in DNA gyrase (*gyrA*) and Topoisomerase IV (*parC*), or through decreased permeability and efflux pumps. * **Rifamycins (e.g., Rifampicin):** Resistance occurs almost exclusively through **mutations in the *rpoB* gene**, which encodes the beta-subunit of bacterial RNA polymerase, altering the drug's binding site. * **Glycopeptides (e.g., Vancomycin):** Resistance (seen in VRE) is due to **target site modification**, where the terminal D-Ala-D-Ala of the peptidoglycan precursor is replaced by D-Ala-D-Lac or D-Ala-D-Ser, reducing the drug's affinity. **High-Yield Clinical Pearls for NEET-PG:** * **Amikacin** is often the most resistant aminoglycoside to these enzymes because its side chain protects it from many AMEs. * **Beta-lactams** also utilize enzyme inactivation (Beta-lactamases) as a major mechanism, but among the options provided, Aminoglycosides are the classic example. * **Mnemonic for Aminoglycoside Resistance:** **A**cetylation, **P**hosphorylation, **A**denylation (**APA** enzymes).

Q: In multidrug-resistant tuberculosis (MDR TB), Mycobacterium tuberculosis is resistant to which combination of first-line drugs?

Isoniazid and Rifampicin. ### Explanation **Correct Answer: C. Isoniazid and Rifampicin** **1. Underlying Medical Concept:** Multidrug-resistant tuberculosis (MDR-TB) is strictly defined by the World Health Organization (WHO) as tuberculosis caused by *Mycobacterium tuberculosis* strains that show *in vitro* resistance to at least **Isoniazid (H)** and **Rifampicin (R)**. These two drugs are the "backbone" of first-line antitubercular therapy (ATT). Resistance to Rifampicin is considered the most critical factor because it necessitates the use of more toxic and less effective second-line regimens. **2. Analysis of Incorrect Options:** * **Options A, B, and D:** While resistance can develop against Ethambutol or Pyrazinamide, resistance to these drugs alone (or in combination with only one of the primary drugs) does not meet the clinical definition of MDR-TB. Resistance to any single first-line drug is termed **Mono-resistance**, while resistance to more than one first-line drug (excluding the H+R combination) is termed **Poly-resistance**. **3. High-Yield Clinical Pearls for NEET-PG:** * **XDR-TB (Extensively Drug-Resistant):** Defined as MDR-TB plus resistance to at least one **Fluoroquinolone** (e.g., Levofloxacin/Moxifloxacin) AND at least one **Group A drug** (Bedaquiline or Linezolid) according to updated WHO definitions. * **Pre-XDR-TB:** MDR-TB plus resistance to any Fluoroquinolone. * **Molecular Basis of Resistance:** * **Isoniazid:** Mutations in the *katG* gene (most common) or *inhA* promoter. * **Rifampicin:** Mutations in the *rpoB* gene (the "hotspot" region). * **Diagnostic Gold Standard:** CBNAAT (GeneXpert) is the preferred initial test as it detects *M. tuberculosis* and Rifampicin resistance simultaneously within 2 hours.

Q: New Delhi metallo-beta-lactamase enzyme confers resistance to which antibiotic class?

Carbapenems. **Explanation:** **New Delhi metallo-beta-lactamase (NDM-1)** is a specific type of **carbapenemase** enzyme. It belongs to the Ambler Class B category of beta-lactamases. The core mechanism of NDM-1 involves the use of zinc ions at its active site to hydrolyze the beta-lactam ring, thereby inactivating almost all beta-lactam antibiotics, most notably **Carbapenems** (e.g., Imipenem, Meropenem). This makes it a significant public health threat as carbapenems are often the "drugs of last resort" for multidrug-resistant Gram-negative infections. **Analysis of Options:** * **A. Colistin:** This is a polymyxin antibiotic that acts on the bacterial cell membrane. Resistance to colistin is typically mediated by the *mcr-1* gene, not beta-lactamases. * **B. Amoxicillin:** While NDM-1 does confer resistance to penicillins like amoxicillin, the defining clinical significance and the "metallo-beta-lactamase" classification specifically highlight its ability to destroy **Carbapenems**, which are usually resistant to standard beta-lactamases. * **D. Vancomycin:** This is a glycopeptide that inhibits cell wall synthesis in Gram-positive bacteria. NDM-1 is primarily found in Gram-negative Enterobacteriaceae (like *E. coli* and *K. pneumoniae*), which are intrinsically resistant to Vancomycin due to their outer membrane. **High-Yield Clinical Pearls for NEET-PG:** 1. **Aztreonam Exception:** NDM-1 producers are typically resistant to all beta-lactams **except Monobactams (Aztreonam)**. However, in clinical practice, these bacteria often co-produce other enzymes that degrade Aztreonam. 2. **Inhibition:** Metallo-beta-lactamases are inhibited by **EDTA** (a chelating agent) but **not** by traditional inhibitors like Clavulanic acid or Sulbactam. 3. **Detection:** The **Modified Hodge Test** or the **mCIM** (Carbapenem Inactivation Method) are used for laboratory detection.

Q: What is the most likely explanation for multiple drug resistance to antibiotics that spreads from one type of bacteria to another?

Gene transfer. **Explanation:** The correct answer is **Gene transfer**. The spread of multiple drug resistance (MDR) across different bacterial species is primarily driven by **Horizontal Gene Transfer (HGT)**. This occurs through three main mechanisms: **Conjugation** (plasmid-mediated), **Transformation** (uptake of naked DNA), and **Transduction** (bacteriophage-mediated). Among these, conjugation involving **R-plasmids** is the most common cause of rapid, widespread MDR in clinical settings. **Why other options are incorrect:** * **Adaptation:** This is a physiological response to environmental stress (e.g., forming a biofilm) rather than a genetic change. It is temporary and not heritable or transferable between species. * **Mutation:** While mutations (vertical evolution) can cause resistance, they are random, spontaneous events that occur within a single lineage. Mutations explain resistance to a single drug (e.g., Rifampicin resistance in *M. tuberculosis*) but cannot explain the rapid, simultaneous spread of resistance to multiple drugs across different genera. * **Decreased Bioavailability:** This is a pharmacokinetic term referring to the fraction of an administered drug that reaches systemic circulation. It relates to drug absorption, not bacterial resistance mechanisms. **High-Yield Clinical Pearls for NEET-PG:** * **Transposons ("Jumping Genes"):** These are DNA sequences that move between plasmids and chromosomes, often carrying resistance genes (e.g., *vanA* gene for Vancomycin resistance). * **Integrons:** Genetic assemblies that can capture and express multiple gene cassettes, acting as a major reservoir for MDR. * **ESBL (Extended Spectrum Beta-Lactamase):** Often plasmid-encoded, making organisms like *E. coli* and *Klebsiella* resistant to most cephalosporins.

Q: Pneumococcal resistance to penicillin G is mainly acquired by:

Transformation. **Explanation:** **1. Why Transformation is Correct:** *Streptococcus pneumoniae* (Pneumococcus) is naturally **competent**, meaning it has the innate ability to take up exogenous DNA from its environment. Resistance to Penicillin G in Pneumococci is not mediated by beta-lactamase production; instead, it occurs through the **alteration of Penicillin-Binding Proteins (PBPs)**, specifically PBP 2b, 2x, and 1a. The bacteria acquire "foreign" PBP genes from related oral streptococci (like *S. mitis*) via **Transformation**. This results in the formation of **mosaic genes**, which encode PBPs with a significantly decreased affinity for penicillin, leading to resistance. **2. Why Other Options are Incorrect:** * **Conjugation (A):** This involves the transfer of genetic material (usually plasmids) through direct cell-to-cell contact via a sex pilus. While common in Gram-negative enteric bacteria (e.g., *E. coli*), it is not the primary mechanism for penicillin resistance in Pneumococci. * **Transduction (B):** This is the transfer of DNA from one bacterium to another via a bacteriophage (virus). While it occurs in *Staphylococci* (e.g., for penicillinase plasmids), it is not the mechanism for PBP alteration in *S. pneumoniae*. **3. NEET-PG High-Yield Pearls:** * **Mechanism of Resistance:** Remember: Pneumococcus = **Mosaic PBPs** (via Transformation); Staphylococcus = **Beta-lactamase** (via Transduction) or **mecA gene/PBP2a** (for MRSA). * **Griffith Experiment:** The classic "Mouse and Pneumococcus" experiment (Smooth vs. Rough strains) was the first to demonstrate the "Transforming Principle." * **Drug of Choice:** For highly penicillin-resistant Pneumococci, **Vancomycin** or **Linezolid** are typically used. * **Other naturally competent bacteria:** *Haemophilus influenzae*, *Neisseria gonorrhoeae*, and *Bacillus subtilis*.

Question 1

A 65-year-old male underwent emergency laparotomy for perforated duodenal ulcer 5 days ago. He now develops fever (38.5°C), productive cough, and increased oxygen requirement. Chest X-ray shows a new right lower lobe infiltrate. Gram stain of endotracheal aspirate shows Gram-negative bacilli, and culture grows lactose-fermenting colonies that are oxidase-negative and produce a metallic sheen on EMB agar. The isolate is resistant to ampicillin and third-generation cephalosporins but sensitive to cefoxitin (a cephamycin). Resistance is inhibited by clavulanic acid in disk synergy testing. The isolate is also resistant to fluoroquinolones, but sensitive to carbapenems and colistin. What is the most likely mechanism of antibiotic resistance in this organism?

Accepted Answer

Extended-spectrum beta-lactamase (ESBL) production

Answer

AmpC beta-lactamase hyperproduction

Answer

Carbapenemase production

Answer

Porin channel mutation with efflux pump overexpression

Question 2

A cluster of pneumonia cases is reported from a city with high mortality rate. Sputum cultures show gram-negative coccobacilli resistant to multiple antibiotics including carbapenems. Gene sequencing reveals blaNDM-1. What is the most critical factor contributing to this emerging resistance?

Accepted Answer

Horizontal gene transfer through plasmids

Answer

Point mutations in chromosomal DNA

Answer

Decreased porin expression

Answer

Efflux pump mechanisms only

Question 3

Which of the following drugs should not be used to treat Klebsiella infection?

Accepted Answer

Ampicillin

Answer

Amikacin

Answer

Imipenem

Answer

Tigecycline

Question 4

Enzyme inactivation is the main mode of resistance to which class of antibiotics?

Accepted Answer

Aminoglycosides

Answer

Quinolones

Answer

Rifamycins

Answer

Glycopeptides

Question 5

Which of the following is true regarding Methicillin-resistant Staphylococcus aureus (MRSA)?

Accepted Answer

Pulse field gel electrophoresis is useful in the investigation of an MRSA outbreak.

Answer

It is resistant to iodine solution.

Answer

It can be transmitted via the air-conditioning system.

Answer

It primarily causes deeper infections.

Question 6

In multidrug-resistant tuberculosis (MDR TB), Mycobacterium tuberculosis is resistant to which combination of first-line drugs?

Accepted Answer

Isoniazid and Rifampicin

Answer

Isoniazid and Ethambutol

Answer

Rifampicin and Ethambutol

Answer

Isoniazid and Pyrazinamide

Question 7

New Delhi metallo-beta-lactamase enzyme confers resistance to which antibiotic class?

Accepted Answer

Carbapenems

Answer

Colistin

Answer

Amoxicillin

Answer

Vancomycin

Question 8

What is the most likely explanation for multiple drug resistance to antibiotics that spreads from one type of bacteria to another?

Accepted Answer

Gene transfer

Answer

Adaptation

Answer

Mutation

Answer

Decreased bioavailability

Question 9

Multiple drug resistance of bacteria depends on which of the following?

Accepted Answer

Resistance transfer factor (RTF)

Answer

Colicigenic factor (Col)

Answer

Fertility factor (F+)

Answer

All of the above

Question 10

Pneumococcal resistance to penicillin G is mainly acquired by:

Accepted Answer

Transformation

Answer

Conjugation

Answer

Transduction

Answer

All of the above

Antimicrobial Resistance — MCQs

Antimicrobial Resistance — MCQs

On this page

Practice by Chapter

Want unlimited practice?